Canesten Cutaneous Solution 1% Clotrimazole Antifungal 40ml

NAME
CANESTEN

PHARMACOTHERAPEUTIC CATEGORY
Topical antifungals, imidazole and triazole derivatives.

ACTIVE PRINCIPLES
Clotrimazole.

EXCIPIENTS
Cream 1%: sorbitan stearate, polysorbate 60, cetyl palmitate, cetostearyl alcohol, octyldodecanol, benzyl alcohol, purified water. Skin spray, 1% solution in multidose container with metering pump: macrogol 400, isopropanol, propylene glycol. Skin powder 1%: rice starch.

INDICATIONS
Cream and skin spray solution: mycosis of the skin and skin folds, such as pityriasis versicolor, skin candidiasis, tinea pedis or athlete's foot, tinea corporis. Skin powder: topical treatment of humid hemicosis of the skin and skin folds especially if localized in covered or poorly ventilated areas (for example: athlete's tinea pedis opiede, tinea cruris, tinea inguinalis).

CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the listed excipients.

DOSAGE
Cream: it should be applied in small quantities 2-3 times a day in correspondence with the affected area, rubbing lightly, after having carefully washed and dried the part. Half a cm of cream is enough to treat a surface the size of a hand. The cream is electively indicated for the treatment of hairless (hairless) skin areas. Skin spray solution: it is useful for the treatment of skin areas covered by hair and in correspondence with skin folds. It is also suitable for application on large areas of the body (back, abdomen, chest). The cutaneous spray solution must be sprayed evenly on the area to be treated 2 times a day. Skin powder: it should be applied 2-3 times a day, after having thoroughly washed and dried the affected area. In athlete's foot it is advisable to sprinkle the inside of the socks and shoes with the powder. Generally for the disappearance of the manifestations, a treatment period without interruption of three to four weeks is sufficient. In order to consolidate the therapeutic results obtained and avoid reinfection, it is advisable to continue therapy with the medicine for at least two weeks after the disappearance of manifestations.

STORAGE
This medicine does not require any special storage conditions.

WARNINGS
Avoid contact with eyes. Do not swallow. The use, especially if prolonged, of products for topical use, can give rise to sensitization phenomena. In this case, it is necessary to stop the treatment and consult your doctor or pharmacist. In diaper dermatitis, the use of diapers with an occlusive effect is not recommended after applying the drug. Skin spray solution: avoid splashing into the eyes. Cream: contains cetostearyl alcohol which can cause local skin reactions (eg contact dermatitis). 1% cutaneous spray solution (multidose container with dosing pump): contains propylene glycol which can cause skin irritation.

INTERACTIONS
None known.

SIDE EFFECTS
The following adverse reactions were identified after the approval of clotrimazole. Since these reactions derive from spontaneous reports from a population of uncertain size, it is not always possible to define their frequency. Immune system disorders: allergic reaction (syncope, hypotension, dyspnoea, urticaria). Skin and subcutaneous tissue disorders: blisters, discomfort / pain, edema, erythema, irritation, peeling, itching, rash, burning.

PREGNANCY AND BREASTFEEDING
No human studies have been conducted on the effects of clotrimazole on fertility '; however, animal studies have shown no effects of the drug on fertility. There is a limited amount of data on the use of clotrimazole in pregnancy. Animal studies do not show any direct or indirect harmful effects in terms of reproductive toxicity. As a precautionary measure, the use of clotrimazole in the first trimester of pregnancy should be avoided. Available pharmacodynamic / toxicological data in animals have demonstrated secretion of clotrimazole / metabolites in milk. Breastfeeding should be discontinued during treatment with clotrimazole.